首页> 外国专利> RYANODINE RECEPTOR ACTIVATION AGENT AND USE THEREOF

RYANODINE RECEPTOR ACTIVATION AGENT AND USE THEREOF

机译:瑞丹定受体激活剂及其用途

摘要

PROBLEM TO BE SOLVED: To provide a ryanodine receptor activation agent and use thereof.;SOLUTION: The present invention provides an activation agent for a ryanodine receptor expressed in a neural cell and use thereof, which contains as an active ingredient a substance selected from a group consisting of carbon monoxide, carbon monoxide donor, carbon monoxide generation inducing substance and carbon monoxide metabolism inhibitor. Further, the present invention provides a ryanodine receptor relating disease therapeutic medicine or a monoamine relating disease therapeutic medicine, and use thereof, in which the ryanodine receptor relating disease therapeutic medicine or the monoamine relating disease therapeutic medicine contains as a medicinal ingredient a substance selected from a group consisting of carbon monoxide, carbon monoxide donor, carbon monoxide generation inducing substance and carbon monoxide metabolism inhibitor, and the ryanodine receptor relating disease therapeutic medicine or the monoamine relating disease therapeutic medicine contains as a medicinal ingredient carbon monoxide generation suppressor.;SELECTED DRAWING: Figure 9;COPYRIGHT: (C)2019,JPO&INPIT
机译:解决的问题:提供一种莱丹定受体活化剂及其用途。解决方案:本发明提供一种用于神经细胞中表达的莱丹定受体活化剂及其用途,其包含选自以下物质的活性成分作为活性成分。一氧化碳,一氧化碳供体,一氧化碳生成诱导物质和一氧化碳代谢抑制剂组成的组。此外,本发明提供了一种与雷诺定受体有关的疾病治疗药物或与单胺有关的疾病治疗药物及其用途,其中所述与雷诺丁受体有关的疾病治疗药物或与单胺有关的疾病治疗药物包含选自以下的物质作为药物成分:一氧化碳,一氧化碳供体,一氧化碳生成诱导物质和一氧化碳代谢抑制剂和与雷诺丁受体相关的疾病治疗药物或与单胺相关的疾病治疗药物组成的组包含一氧化碳生成抑制剂作为药用成分。 :图9;版权:(C)2019,JPO&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号